BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33059497)

  • 1. Update on: effects of anti-diabetic drugs on bone metabolism.
    Mabilleau G; Bouvard B
    Expert Rev Endocrinol Metab; 2020 Nov; 15(6):415-430. PubMed ID: 33059497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-diabetic drugs on bone metabolism: Evidence from preclinical and clinical studies.
    Adil M; Khan RA; Kalam A; Venkata SK; Kandhare AD; Ghosh P; Sharma M
    Pharmacol Rep; 2017 Dec; 69(6):1328-1340. PubMed ID: 29132091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health in diabetes: considerations for clinical management.
    Adami S
    Curr Med Res Opin; 2009 May; 25(5):1057-72. PubMed ID: 19292601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and fracture healing: the skeletal effects of diabetic drugs.
    Simpson CM; Calori GM; Giannoudis PV
    Expert Opin Drug Saf; 2012 Mar; 11(2):215-20. PubMed ID: 22145960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes increases the risk of fractures].
    Starup-Linde J; Karahasanovic A; Vestergaard P; Eiken P
    Ugeskr Laeger; 2015 Nov; 177(49):V08150663. PubMed ID: 26651553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The placebo response of injectable GLP-1 receptor agonists vs. oral DPP-4 inhibitors and SGLT-2 inhibitors: a systematic review and meta-analysis.
    de Wit HM; Te Groen M; Rovers MM; Tack CJ
    Br J Clin Pharmacol; 2016 Jul; 82(1):301-14. PubMed ID: 26935973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis and risk of fracture in patients with diabetes: an update.
    Montagnani A; Gonnelli S; Alessandri M; Nuti R
    Aging Clin Exp Res; 2011 Apr; 23(2):84-90. PubMed ID: 21743287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diabetes Mellitus and bone metabolism].
    Okazaki R
    Clin Calcium; 2011 May; 21(5):669-75. PubMed ID: 21532115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and bone health.
    Antonopoulou M; Bahtiyar G; Banerji MA; Sacerdote AS
    Maturitas; 2013 Nov; 76(3):253-9. PubMed ID: 23628280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of fracture caused by anti-diabetic drugs in individuals with type 2 diabetes: A network meta-analysis.
    Tsai WH; Kong SK; Lin CL; Cheng KH; Cheng YT; Chien MN; Lee CC; Tsai MC
    Diabetes Res Clin Pract; 2022 Oct; 192():110082. PubMed ID: 36122867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes Drug Effects on the Skeleton.
    Chandran M
    Calcif Tissue Int; 2017 Feb; 100(2):133-149. PubMed ID: 27815568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing and maintaining bone mineral density in diabetes patients with pharmacotherapy.
    Fixen CW; Fixen DR
    Expert Opin Pharmacother; 2017 Dec; 18(18):2001-2006. PubMed ID: 29172834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the cardiovascular risk with non-insulin antidiabetic drugs.
    Athyros VG; Imprialos K; Stavropoulos K; Sahinidis A; Doumas M
    Expert Opin Drug Saf; 2019 Mar; 18(3):241-251. PubMed ID: 30810055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone effects of glitazones and other anti-diabetic drugs.
    Rejnmark L
    Curr Drug Saf; 2008 Sep; 3(3):194-8. PubMed ID: 18691001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials.
    Giugliano D; Maiorino MI; Longo M; Bellastella G; Chiodini P; Esposito K
    Endocrine; 2019 Jul; 65(1):15-24. PubMed ID: 31028667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of anti-diabetes drugs.
    Younk LM; Lamos EM; Davis SN
    Expert Opin Drug Saf; 2016 Sep; 15(9):1239-57. PubMed ID: 27268470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.
    Cheng L; Hu Y; Li YY; Cao X; Bai N; Lu TT; Li GQ; Li N; Wang AN; Mao XM
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3168. PubMed ID: 30974033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and the skeleton: new insights into sweet bones.
    Shanbhogue VV; Mitchell DM; Rosen CJ; Bouxsein ML
    Lancet Diabetes Endocrinol; 2016 Feb; 4(2):159-73. PubMed ID: 26365605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of thiazolidinediones on bone loss and fracture.
    Murphy CE; Rodgers PT
    Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes mellitus and bone].
    Kanazawa I; Sugimoto T
    Clin Calcium; 2016 Aug; 26(8):1185-93. PubMed ID: 27461503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.